{
  "Q0": "Whole Exome Sequencing (WES) with trio testing",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4.1": "Yes",
  "Q4.2": "ACMG",
  "Q5": "Yes",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9.1": "Yes",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Yes",
  "Q12": "Yes",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14.1": "81415 (for proband) and 81416 (for parents as part of trio)",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "The policy doesn't specify detailed claim submission steps, but the following should be documented: 1) Evaluation by a clinician with expertise in clinical genetics (Pediatric Neurologist in this case), 2) Genetic counseling was provided about potential risks, 3) Documentation that previous genetic testing (chromosomal microarray and epilepsy gene panel) was non-diagnostic, 4) Clinical presentation showing potential for change in management, 5) Trio testing information for parents.",
  "match": false
}